Phototherapeutic Keratectomy for Salzmann's Nodular Degeneration. What Effect Does the Choice of Excimer Laser Have on Treatment Success? / Phototherapeutische Keratektomie bei Salzmannʼscher nodulärer Degeneration. Welche Auswirkung hat die Wahl des Excimerlasers auf den Erfolg der Behandlung?

ABSTRACT

PURPOSE: The aim of this study was to assess the difference in treatment success after phototherapeutic keratectomy (PTK) for Salzmann's nodular degeneration (SND) using two excimer lasers with different specifications. PATIENTS AND METHODS: 272 PTK procedures, which had been performed on 246 eyes with SND from 181 patients, were retrospectively examined in the period from 2007 to 2017. Until 2014 the excimer laser MEL70 (Carl Zeiss Meditec Vertriebsgesellschaft mbH, Oberkochen, Germany) was used for PTK following manual pannectomy, and after 2014 the excimer laser Amaris 750S (Schwind eye-tech-solutions GmbH, Kleinostheim, Germany) was used. Treatment success was assessed on basis of visual acuity, refraction, and astigmatism, as well as pachymetry and endothelial cell count, recorded at the following time points T1 = preoperative, T2 = 6-week follow-up, T3 = 6-month follow-up. The Wilcoxon-Mann-Whitney U test and the chi-square test with a significance level of 5% were used to compare the data. RESULTS: A significantly higher improvement of 0.17 ± 0.33 logMAR could be shown for visual acuity in the Schwind group (p < 0.013) after 6 months. In the Zeiss group, visual acuity improved by only 0.11 ± 0.36 (logMAR p < 0.057). Regarding refraction, a significant reduction of the spherical equivalent (SEQ) (p < 0.001) by 3.35 ± 2.76 diopters (D) after 6 months could only be shown for the Schwind group. SEQ did not change significantly in the Zeiss group (p < 0.676). The topographic astigmatism was significantly improved after 6 months in both study groups, by 1.73 ± 1.99 D in the Schwind group (p < 0.001) and by 1.99 ± 2.21 D in the Zeiss group (p < 0.0001). Haze had to be treated in 12.7% of the cases in the Schwind group and in 16.2% of the cases in the Zeiss group. No endothelial cell damage was found in either group. CONCLUSIONS: In both study groups, the patients with SND clearly benefited from PTK. However, a significantly higher advantage for visual acuity and refraction was shown for the Schwind group compared with the Zeiss group. In contrast to the usual hyperopic effect of PTK in other diagnoses, PTK in SND showed a "myopic shift", which can be explained by the often midperipheral SND nodes and the associated asymmetric tear film pooling prior to surgery.